News | November 08, 2024
Abbott India reports Q2 FY25 standalone PAT at Rs. 358.61 Cr
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
The company has reported total income of Rs. 1,693.15 crores during the period ended September 30, 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
Apollo Hospitals Enterprise has reported total income of Rs. 5,627.5 crores during the period ended September 30, 2024
US Generics grew 5% to Rs. 467 Crores for the quarter
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revenue from Operations during Q2 FY25 was Rs. 3,077 crore as compared to Rs. 2,708 crore in Q2 FY24.
Dr. Reddy's Laboratories has reported total income of Rs. 8,016.2 crores during the period ended September 30, 2024
Revenue share from the North America increased to 79% in Q2 FY25 as compared to 67% in Q2 FY24
The company has reported total income of Rs. 1,465.49 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
